Gene-Expression - Based Responses to Drug Treatment.

Area of Science:

• Pharmacology and Toxicology
• Genomics and Bioinformatics

Background:

• Many drug candidates fail due to late-stage toxicity or lack of efficacy.
• Early assessment of drug properties is crucial for successful drug development.
• DNA microarrays offer a method to gain deeper insights into compound behavior.

Purpose of the Study:

• To review the application and impact of gene expression profiling in drug discovery and development.
• To evaluate the extent to which DNA microarray technology has fulfilled its promise.
• To assess the utility of expression profiling across various stages of the pharmaceutical pipeline.

Main Methods:

• Gene expression profiling using DNA microarrays.
• Analysis of gene expression data to create "expression fingerprints."
• Application of these fingerprints in target identification, validation, and mode of action studies.

Main Results:

• DNA microarrays facilitate drug target identification and validation.
• Expression profiling aids in elucidating the mechanism of action for novel compounds.
• This technology assists in discovering biomarkers for diagnostics, prognostics, and predicting adverse effects.

Conclusions:

• Gene expression profiling using DNA microarrays is a valuable tool throughout drug discovery and development.
• It enhances early-stage understanding of drug properties, including efficacy and toxicity.
• The technology shows significant promise for improving the efficiency and success rate of bringing new drugs to market.